MA (EU) number 
(Invented) 
name 
Strength 
Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Pack size 
EU/1/15/1019/001 
EU/1/15/1019/002 
EU/1/15/1019/003 
EU/1/15/1019/004 
EU/1/15/1019/005 
EU/1/15/1019/006 
Bortezomib 
Accord   
Bortezomib 
Accord   
Bortezomib 
Accord   
Bortezomib 
Accord   
Bortezomib 
Accord   
Bortezomib 
Accord   
3.5 mg 
1 mg 
2.5 mg/ml 
Powder for solution 
for injection 
Powder for solution 
for injection 
Solution for injection 
2.5 mg/ml 
Solution for injection 
2.5 mg/ml 
Solution for injection 
2.5 mg/ml 
Solution for injection 
Intravenous use, 
Subcutaneous use 
Intravenous use 
Intravenous use, 
Subcutaneous use 
Intravenous use, 
Subcutaneous use 
Intravenous use, 
Subcutaneous use 
Intravenous use, 
Subcutaneous use 
vial (glass) 
vial (glass) 
vial (glass) 
vial (glass) 
vial (glass) 
vial (glass) 
1 vial 
1 vial 
1 vial  
4 vials  
1 vial  
4 vials  
1/1 
 
 
